Stocktoria
Nuvation Bio Inc. NUVB
NYSE · XNYS · stock · Pharmaceutical Preparations · website · IPO 2020-07-01
Chart by TradingView
4/9
Piotroski F — financial health
-2.01
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $62.9M | $7.9M | $0 | — | — |
| Gross profit | — | $795,000 | $0 | — | — |
| Operating income | -$213.1M | -$592.6M | -$99.8M | -$119.7M | -$93.3M |
| Net income | -$204.6M | -$567.9M | -$75.8M | -$104.2M | -$86.8M |
| Operating cash flow | -$173.4M | -$130.4M | -$68.0M | -$96.1M | -$68.2M |
| Total assets | $594.8M | $540.6M | $621.5M | $672.1M | $776.2M |
| Total liabilities | $289.1M | $76.8M | $16.4M | $17.1M | $30.2M |
| Shareholders' equity | $305.7M | $463.8M | $605.1M | $655.1M | $746.0M |
| Ratios | |||||
| Gross margin | — | 10.1% | — | — | — |
| Operating margin | -338.7% | -7527.3% | — | — | — |
| Net margin | -325.3% | -7213.8% | — | — | — |
| Return on assets | -34.4% | -105.1% | -12.2% | -15.5% | -11.2% |
| Return on equity | -66.9% | -122.5% | -12.5% | -15.9% | -11.6% |
| Debt / equity | 0.15× | — | — | — | — |
| Current ratio | 6.95 | 9.04 | 44.11 | 50.70 | 45.62 |
| Revenue growth | 699.0% | — | — | — | — |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 559,180 | $2.4M |
| GREENLIGHT CAPITAL INC | 34,995 | $52,842 |
| Duquesne Family Office LLC | 4,539,800 | $19,476 |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -2.01 (distress)
- Working capital / assets 0.823
- Retained earnings / assets -1.875
- EBIT / assets -0.358
- Equity / liabilities 1.057
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001811063 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.